• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19.

作者信息

Salah Husam M, Mehta Jawahar L

机构信息

Division of Cardiology, Department of Internal Medicine, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas.

Division of Cardiology, Department of Internal Medicine, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas.

出版信息

Am J Cardiol. 2021 Mar 1;142:158-159. doi: 10.1016/j.amjcard.2020.12.073. Epub 2021 Jan 6.

DOI:10.1016/j.amjcard.2020.12.073
PMID:33417877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834714/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc5/7834714/6dd0459a4e71/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc5/7834714/6dd0459a4e71/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bc5/7834714/6dd0459a4e71/gr1_lrg.jpg

相似文献

1
Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19.阿司匹林对新冠病毒疾病死亡率影响的荟萃分析
Am J Cardiol. 2021 Mar 1;142:158-159. doi: 10.1016/j.amjcard.2020.12.073. Epub 2021 Jan 6.
2
Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration.退伍军人事务部 COVID-19 患者的死亡率与阿司匹林处方的关联。
PLoS One. 2021 Feb 11;16(2):e0246825. doi: 10.1371/journal.pone.0246825. eCollection 2021.
3
Can an Old Ally Defeat a New Enemy?一个老盟友能打败一个新敌人吗？
Circulation. 2020 Jul 28;142(4):315-317. doi: 10.1161/CIRCULATIONAHA.120.047830. Epub 2020 Jun 1.
4
Effect of aspirin on coronavirus disease 2019: A nationwide case-control study in South Korea.阿司匹林对 2019 年冠状病毒病的影响：韩国全国范围内的病例对照研究。
Medicine (Baltimore). 2021 Jul 30;100(30):e26670. doi: 10.1097/MD.0000000000026670.
5
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19.秋水仙碱对新型冠状病毒肺炎死亡率及机械通气影响的荟萃分析
Am J Cardiol. 2021 Apr 15;145:170-172. doi: 10.1016/j.amjcard.2021.02.005. Epub 2021 Feb 19.
6
Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis.糖皮质激素治疗与 COVID-19 患者和 SARS 患者死亡率的关联比较：系统评价和荟萃分析。
Shock. 2021 Aug 1;56(2):215-228. doi: 10.1097/SHK.0000000000001738.
7
Just the facts: updates in COVID-19 therapeutics.只讲事实：新冠治疗的最新进展。
CJEM. 2021 May;23(3):283-285. doi: 10.1007/s43678-020-00078-4. Epub 2021 Feb 8.
8
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19.低剂量阿司匹林对 COVID-19 住院成人死亡率和病毒持续时间的影响。
Medicine (Baltimore). 2021 Feb 12;100(6):e24544. doi: 10.1097/MD.0000000000024544.
9
NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown?非甾体抗炎药和 Kelleni 方案作为 COVID-19 早期治疗的潜在改变者：这会是最终倒计时吗？
Inflammopharmacology. 2022 Feb;30(1):343-348. doi: 10.1007/s10787-021-00896-7. Epub 2021 Nov 25.
10
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.阿托伐他汀和阿司匹林作为 SARS-CoV-2 感染患者的辅助治疗：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 30;21(1):902. doi: 10.1186/s13063-020-04840-y.

引用本文的文献

1
The 125th Anniversary of Aspirin-The Story Continues.阿司匹林问世125周年——故事仍在继续。
Pharmaceuticals (Basel). 2024 Mar 28;17(4):437. doi: 10.3390/ph17040437.
2
Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study.COVID-19 感染前的抗血小板治疗对患者死亡率的影响：一项倾向评分匹配队列研究。
Sci Rep. 2024 Feb 28;14(1):4832. doi: 10.1038/s41598-024-55407-9.
3
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review.动脉粥样硬化、心血管疾病与2019冠状病毒病：一篇叙述性综述
Biomedicines. 2023 Apr 18;11(4):1206. doi: 10.3390/biomedicines11041206.
4
Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.2019 年冠状病毒病中涉及血小板活化、高凝状态和纤溶活性降低的血栓形成机制。
Int J Mol Sci. 2023 Apr 28;24(9):7975. doi: 10.3390/ijms24097975.
5
Factors associated with mortality in hospitalised, non-severe, older COVID-19 patients - the role of sarcopenia and frailty assessment.与住院非重症老年 COVID-19 患者死亡率相关的因素-肌肉减少症和衰弱评估的作用。
BMC Geriatr. 2022 Dec 7;22(1):941. doi: 10.1186/s12877-022-03571-w.
6
All-cause and in-hospital mortality after aspirin use in patients hospitalized with COVID-19: a systematic review and meta-analysis.COVID-19住院患者使用阿司匹林后的全因死亡率和院内死亡率：一项系统评价和荟萃分析。
Biol Methods Protoc. 2022 Oct 29;7(1):bpac027. doi: 10.1093/biomethods/bpac027. eCollection 2022.
7
Investigating the association between IL-6 antagonist therapy and blood coagulation in critically ill patients with COVID-19: a protocol for a prospective, observational, multicentre study.探讨白细胞介素 6 拮抗剂治疗与 COVID-19 重症患者凝血功能之间的关系：一项前瞻性、观察性、多中心研究方案。
BMJ Open. 2022 Nov 4;12(11):e063856. doi: 10.1136/bmjopen-2022-063856.
8
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis.阿司匹林或其他抗血小板药物的使用与新冠肺炎患者全因死亡率之间的关联：一项荟萃分析。
Front Pharmacol. 2022 Oct 5;13:989903. doi: 10.3389/fphar.2022.989903. eCollection 2022.
9
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al.“新冠病毒引发的非传统CD147依赖性血小板激活在新冠肺炎中的作用”：和田等人的评论
J Thromb Haemost. 2022 Sep;20(9):2159-2160. doi: 10.1111/jth.15791.
10
Effect of low dose acetylsalicylic acid and anticoagulant on clinical outcomes in COVID-19, analytical cross-sectional study.低剂量乙酰水杨酸和抗凝剂对新型冠状病毒肺炎临床结局的影响，分析性横断面研究
Health Sci Rep. 2022 Jul 11;5(4):e699. doi: 10.1002/hsr2.699. eCollection 2022 Jul.